Halozyme Therapeutics, Inc. (HALO): Price and Financial Metrics

Halozyme Therapeutics, Inc. (HALO): $55.15

0.25 (-0.45%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add HALO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#18 of 341

in industry

HALO Price/Volume Stats

Current price $55.15 52-week high $56.50
Prev. close $55.40 52-week low $32.83
Day low $54.54 Volume 968,626
Day high $55.68 Avg. volume 1,256,560
50-day MA $49.55 Dividend yield N/A
200-day MA $40.90 Market Cap 7.02B

HALO Stock Price Chart Interactive Chart >


Halozyme Therapeutics, Inc. (HALO) Company Bio


Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. The company was founded in 1998 and is based in San Diego, California.


HALO Latest News Stream


Event/Time News Detail
Loading, please wait...

HALO Latest Social Stream


Loading social stream, please wait...

View Full HALO Social Stream

Latest HALO News From Around the Web

Below are the latest news stories about HALOZYME THERAPEUTICS INC that investors may wish to consider to help them evaluate HALO as an investment opportunity.

Insider Sell Alert: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of ...

Halozyme Therapeutics Inc (NASDAQ:HALO), a biopharmaceutical company known for its novel enzyme technology that targets the extracellular matrix, has recently witnessed a significant insider sell transaction.

Yahoo | December 15, 2023

3 Reasons Growth Investors Will Love Halozyme Therapeutics (HALO)

Halozyme Therapeutics (HALO) possesses solid growth attributes, which could help it handily outperform the market.

Yahoo | December 14, 2023

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | December 8, 2023

Why Is Halozyme Therapeutics (HALO) Up 2.8% Since Last Earnings Report?

Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 6, 2023

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | December 5, 2023

Read More 'HALO' Stories Here

HALO Price Returns

1-mo 5.94%
3-mo 43.40%
6-mo 61.21%
1-year 28.83%
3-year 28.58%
5-year 228.47%
YTD 49.22%
2023 -35.04%
2022 41.51%
2021 -5.85%
2020 140.89%
2019 21.19%

Continue Researching HALO

Want to see what other sources are saying about Halozyme Therapeutics Inc's financials and stock price? Try the links below:

Halozyme Therapeutics Inc (HALO) Stock Price | Nasdaq
Halozyme Therapeutics Inc (HALO) Stock Quote, History and News - Yahoo Finance
Halozyme Therapeutics Inc (HALO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!